GTH 2023: The Patient as a Benchmark

Hamostaseologie 2023; 43(01): 005-006
DOI: 10.1055/a-1916-7764

Editorial

Authors

Wolfgang Miesbach

¹Medical Clinic 2, Institute of Transfusion Medicine, University Hospital Frankfurt
Erhard Seifried

²Blood transfusion centre of the German Red cross, Institut of Transfusion Medicine and Immunhaematology, University hospital Frankfurt

References
1 Van Remmoortel H, De Buck E, Seifried E. et al. Evidence-Based Medicine: principles and values as illustrated by the case of Patient Blood Management. Hamostaseologie 2022; 43: 16-21
2 Uzun G, Althaus K, Hammer S. et al. Diagnostic performance of a particle gel immunoassay in vaccine-induced immune thrombotic thrombocytopenia. Hamostaseologie 2022; 43: 22-27
3 Schrezenmeier H, Hoffmann S, Hofmann H. et al. Immune plasma for treatment of COVID-19: lessons learned so far. Hamostaseologie 2022; 43: 67-74
4 Zieger B, Boeckelmann D. Inherited platelet disorders - a short introduction. Hamostaseologie 2022; 43: 52-59
5 O'Donnell J, Baker R. Low VWF - a bleeding disorder of unknown cause?. Hamostaseologie 2022; 43: 44-51
6 Beyer-Westendorf J, Köhler C. DOAC's: Laboratory challenges and antidotes. Hamostaseologie 2022; 43: 37-43
7 Sachs UJ. Pitfalls in coagulation testing. Hamostaseologie 2022; 43: 60-66
8 Koulas I, Spyropoulos AC. A Review of FXIa inhibition as a Novel Target for Anticoagulation. Hamostaseologie 2022; 43: 28-36